Show simple item record

dc.contributor.authorWebb, EA
dc.contributor.authorElliott, L
dc.contributor.authorCarlin, D
dc.contributor.authorWilson, M
dc.contributor.authorHall, K
dc.contributor.authorNetherton, J
dc.contributor.authorReed, J
dc.contributor.authorBarrett, TG
dc.contributor.authorSalwani, V
dc.contributor.authorClayden, JD
dc.contributor.authorArlt, W
dc.contributor.authorKrone, N
dc.contributor.authorPeet, AC
dc.contributor.authorWood, AG
dc.date.accessioned2019-02-25T16:30:49Z
dc.date.issued2018-04
dc.identifier.citationThe Journal of clinical endocrinology and metabolism, 2018, 103 (4), pp. 1330 - 1341
dc.identifier.issn0021-972X
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3092
dc.identifier.eissn1945-7197
dc.identifier.doi10.1210/jc.2017-01481
dc.description.abstractContext:Brain white matter hyperintensities are seen on routine clinical imaging in 46% of adults with congenital adrenal hyperplasia (CAH). The extent and functional relevance of these abnormalities have not been studied with quantitative magnetic resonance imaging (MRI) analysis. Objective:To examine white matter microstructure, neural volumes, and central nervous system (CNS) metabolites in CAH due to 21-hydroxylase deficiency (21OHD) and to determine whether identified abnormalities are associated with cognition, glucocorticoid, and androgen exposure. Design, Setting, and Participants:A cross-sectional study at a tertiary hospital including 19 women (18 to 50 years) with 21OHD and 19 age-matched healthy women. Main Outcome Measure:Recruits underwent cognitive assessment and brain imaging, including diffusion weighted imaging of white matter, T1-weighted volumetry, and magnetic resonance spectroscopy for neural metabolites. We evaluated white matter microstructure by using tract-based spatial statistics. We compared cognitive scores, neural volumes, and metabolites between groups and relationships between glucocorticoid exposure, MRI, and neurologic outcomes. Results:Patients with 21OHD had widespread reductions in white matter structural integrity, reduced volumes of right hippocampus, bilateral thalami, cerebellum, and brainstem, and reduced mesial temporal lobe total choline content. Working memory, processing speed, and digit span and matrix reasoning scores were reduced in patients with 21OHD, despite similar education and intelligence to controls. Patients with 21OHD exposed to higher glucocorticoid doses had greater abnormalities in white matter microstructure and cognitive performance. Conclusion:We demonstrate that 21OHD and current glucocorticoid replacement regimens have a profound impact on brain morphology and function. If reversible, these CNS markers are a potential target for treatment.
dc.formatPrint
dc.format.extent1330 - 1341
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectBrain
dc.subjectHumans
dc.subjectAdrenal Hyperplasia, Congenital
dc.subjectCholine
dc.subjectGlucocorticoids
dc.subjectMagnetic Resonance Imaging
dc.subjectMagnetic Resonance Spectroscopy
dc.subjectCross-Sectional Studies
dc.subjectCognition
dc.subjectNeuropsychological Tests
dc.subjectPsychometrics
dc.subjectDose-Response Relationship, Drug
dc.subjectQuality of Life
dc.subjectAdolescent
dc.subjectAdult
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectYoung Adult
dc.titleQuantitative Brain MRI in Congenital Adrenal Hyperplasia: In Vivo Assessment of the Cognitive and Structural Impact of Steroid Hormones.
dc.typeJournal Article
dcterms.dateAccepted2017-11-09
rioxxterms.versionofrecord10.1210/jc.2017-01481
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-04
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfThe Journal of clinical endocrinology and metabolism
pubs.declined2019-02-25T11:36:07.953+0000
pubs.issue4
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Magnetic Resonance
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Magnetic Resonance
pubs.publication-statusPublished
pubs.volume103
pubs.embargo.termsNot known
icr.researchteamMagnetic Resonanceen_US
dc.contributor.icrauthorCarlin, Dominic


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0